In April, there was over $9 billion raised by companies in the biotech and biopharma space. Within this blog, we delve into our key findings, and the companies raising these funds. You can subscribe to monthly biotech funding updates over on my LinkedIn to keep up to date with the ever-growing biotech market.



Key findings:


  • The largest amount of money raised was by ICON which raised $2 billion in Post-IPO debt
  • The largest amount raised by a private company was by Xaira Therapeutics, who came out of stealth mode with a huge $1 billion Series A funding round. Talk about making an entrance!
  • $3.23 billion was raised between Pre-Seed and Series F funding rounds. The table below shows the full breakdown.


Round up of amount raised in each funding series (rounded)

companies with grant funding


30,000 Metfora (Arizona, US) is developing a blood test that can quickly recognize chronic lung, and heart disorders, and cancers in their early stages.

40,000 Sona Nanotech Ltd. (Canada) is a nano technology life science firm that has developed two proprietary methods for the manufacture of rod shaped gold nanoparticles.

47,701 BSF Enterprise (UK) is unlocking the next generation of biotech solutions through an acquisition-led growth strategy to drive the development of lab-grown tissues.

54,662 Azure Cell Therapies (Switzerland) is a biotech company that focuses on the diagnosis of Parkinson’s disease by developing next-gen CGTs for neurodegenerative diseases

275,000 Amplified Sciences (Indiana, USA) is a life science diagnostics company focusing on detecting and pre-empting the risks of debilitating diseases.

290,000 BioMark Diagnostics (Canada) is an oncology-focused company, with advanced near-to- market liquid biopsy diagnostic technologies.

649,601 InFlectis BioScience (France) is a private drug discovery company aiming at targeting.

900,000 Basilea Pharmaceutica Ltd. (Switzerland) is a commercial stage biopharmaceutical company.

1,000,000 Scout (California, US) previously Uh-Oh Labs, is a diagnostics and health technology company that works to improve public health by developing low-cost, accurate diagnostics.

1,200,000 Antibody Solutions (California, US) provides antigen design, polyclonal antibody generation, research and drug development for biopharmaceutical companies.

1,596,505 SeaBeLife (France) is a biotechnology company that develops a range of drug candidates intended to block regulated necrosis, based on two families of patented molecules.

1,600,000 Surf Bio (California, US) develops therapeutic solutions for diabetes, oncology, infectious diseases, and gene therapy.

2,500,000 GeneVentiv Therapeutics (North Carolina, US) is a pre-clinical gene therapy company focused on blood diseases and disorders.

2,889,635 Apmonia Therapeutics (France) is a biotech company that develops therapeutic strategies for cancer.

3,000,000 Magnetic Insight (California, US) introduced magnetic particle imaging into the preclinical diagnostic research market.

3,000,000 Selsym Biotech (NC, USA) is a biotechnology developer whose goal is to provide innovative platelet-mimetic therapies for the treatment.

3,900,000 Vedanta Biosciences (Massachusetts, USA) creates microbiome-derived therapies to address immune and infectious diseases by modulating the gut microbiota.

4,400,000 Synedgen (California, US) develops novel therapies and products to reduce infection and inflammation of dermal, oral, mucosal, and ophthalmic surfaces.

5,000,000 UNC Greensboro (North Carolina, US) supports students interested in research careers and plan to pursue a biomedical science PhD.

5,480,000 SNIPR Biome (Denmark) is a operator of a discovery stage biotech company intended to revolutionize the treatment of microbial diseases.

6,200,000 Predictive Oncology (Minnesota, USA) is working with the pharmaceutical, diagnostic, and biotech industries to develop customizable assessment methods.

9,022,556 OSE Immunotherapeutics (France) is an integrated biotechnology company focused on inflammatory disease and cancer treatment.

11,800,000 Denovo Biopharma (California, US) is a privately held biotech company providing a novel biomarker solution to personalize drug development.

12,000,000 Allterum Therapeutics (Texas, US) is a biopharmaceutical company that develops treatments for different types of cancers.

13,100,000 BioVie (Massachusetts, US) is pioneering an innovative therapeutic approach targeting ascites due to liver cirrhosis.


companies with pre-seed funding


500,000 Argon AI (New York, US) is automating life sciences activities in clinical and commercial settings.

500,000 Cell BioEngines (New York, US) focused on curing cancer by developing  ‘Off-the-Shelf’ allogenic Cell Therapies.

500,000 SynsoryBio (Massachusetts, US) is a biotechnology research company that offers next-generation protein therapeutics services.

5,300,000 Somite (Florida, US) is leveraging data and AI to introduce novel cell replacement therapies.


companies with seed funding


30,000 RS BioTherapeutics (Maryland, US) is a research, development, and commercialization company focused on pulminary diseases.

100,000 Plumb Pharmaceuticals (Wisconsin, US) produces super-extended-release formulations of weak-base, small-molecule pharmaceuticals using creative quantload technologies that were developed by the company.

500,000 BioAI Health (New Hampshire, US) is a biotech company that uses AI to improve disease diagnosis and predict patient response to therapy.

202,227 Metallo Bio’s (United Kingdom) focus is on the development of two lead chemicals that represent a pioneering new class of antibiotics.

233,110 AMPED PCR (United Kingdom) produces PCR reagents that outperform industry gold standards while costing a fraction of the price.

294,775 Evolutor (United Kingdom) provides proprietary technology and microbiology to unlock the potential of evolution beyond current possibilities.

350,812 Naegis Pharmaceuticals (Canada) is driven to discover new therapies that target underlying chronic inflammatory processes in eye diseases.

1,200,000 Intellistem (California, US) develops innovative cellular immune cancer treatments.

1,276,266 Yuanbo Biotechnology (Hong Kong) is a provider of clever AI-driven cell manufacturing systems with an emphasis on advancing the regenerative medicine and biotechnology industries.

1,700,000 Neurenati Therapeutics (Canada) is a biotechnology company that develops therapeutics for gastrointestinal rare diseases.

1,800,000 Apollon (Massachusetts, US) develops non-invasive continuous glucose monitoring systems.

2,275,100 SynGenSys (United Kingdom) creates product-specific libraries of synthetic genetic parts for next-generation biomedicines.

3,650,000 Conformation-X Therapeutics (Massachusetts, US) is an immune-oncology focused drug development company.

4,000,000 YonedaLabs (California, US) is an AI-based software that assists chemists in optimizing reaction parameters such as temperature, concentration, and catalyst.

4,000,000 Auristone (Singapore) Providing actionable clinical insights with our epigenomics based workflows and actionable epigenomic information and analyses from proprietary pipelines and predictive models.

4,523,432 Red Arrow Therapeutics (Japan) is a biotech firm that provides systemic cytokine delivery, targeted intratumoral activation, and biological potency.

4,973,608 Glen Clova Scientific (Indiana, US) is a company that developing a new generation of active biological drugs.

6,399,965 AmphiStar (Belgium) is a biotechnology firm that makes sophorolipid products from biobased waste- and side streams.

9,000,000 RevOpsis Therapeutics (Illinois, US) employs the Surrobody platform to tackle vision loss and target diverse eye conditions with potential therapeutics.

10,000,000 GenEditBio (China) is a biotech company that specializes in providing curative gene editing based solutions for genetic diseases.

10,000,000 Outrun TX (United Kingdom) develops a platform for the identification of therapeutics that selectively target the protein degradation pathway.

12,576,913 Seamless Therapeutics (Germany) is reshaping the gene editing paradigm with a novel approach to restoring health in patients.

16,054,907 Infinitopes (United Kingdom) is developer of vaccines for the treatment of cancer.

19,611,194 Siren Biotechnology (California, US) blends two revolutionary therapeutic technologies into one for a novel approach to treating cancer.

20,000,000 Brise Pharma (China) is a clinical stage biopharmaceutical company with a major focus on the development of innovative and highly differentiated treatment solutions for severe pain conditions.


series a funding


4,811,937 Artblood (South Korea) is a cell-based artificial blood production company.

7,621,787 Cyto-Facto (Japan) is a biotechnology company that develops and manufactures CAR-T cell therapies and mesenchymal stem cell products.

13,801,479 Scitech pharma (China) is a drug R&D company, utilizes AI to design and develop innovative drugs, focusing on patient demand and clinical value.

13,815,971 Yizun Biotechnology (China) is a cutting-edge immune cell therapy company that has developed many unique platform technologies.

13,824,757 UniXell Biotechnology (China) is a new-generation cell therapy drug developer, focuses on the development of a new generation of cell therapy drugs.

20,000,000 Reshape Biotech (Denmark) builds lab robots that automate the everyday tasks of microbiologists, from filling plates to analysing images.

21,376,154 Flindr Therapeutics (The Netherlands), a private biotech company develops next-generation precision oncology treatments.

24,600,000 DeepCure (Massachusetts, US) leverages AI and AI-enabled technologies to advance small molecule discovery techniques.

35,000,000 SalubrisBio (Maryland, US) is a clinical-stage biotechnology company dedicated to discovering and developing novel antibody and protein-based therapeutics.

40,000,000 PinkDx (Indiana, US) is a women’s health focused biotechnology company.

40,000,000 Rubedo Life Sciences (California, US) focuses on developing medicines that target the specific cells responsible for aging, known as pathologic cells.

50,000,000 Arnatar Therapeutics (California, US) is a biopharmaceutical company that specializes in the development of novel nucleic acid medications.

54,000,000 Corner Therapeutics (Massachusetts, US) is a biotechnology research company that specializes in the immunotherapy paradigm.

62,000,000 D3 Bio (China) is a biotechnology company focusing on the development and registration of medicines in oncology and immunology.

63,000,000 Neurosterix (Switzerland) is a biopharmaceutical firm dedicated to creating allosteric modulators for the treatment of neurological illnesses.

100,000,000 Enlaza Therapeutics (California, US) is creating a new class of protein therapeutics that deliver more efficacious and safer treatments for patients.

100,000,000 Seaport Therapeutics (Massachusetts, US) is advancing novel antidepressants and anxiolytics based on clinically validated mechanisms using their Glyph™ platform.

128,000,000 Diagonal Therapeutics (Massachusetts, US) is a biotechnology startup that is pioneering a novel technique to finding and producing agonist antibodies.

290,000,000 Metsera (New York, US) operates as a clinical-stage biopharmaceutical company focused on obesity.

1,000,000,000 Xaira Therapeutics (California, US) is an integrated biotechnology company driving advances in artificial intelligence to learn the language of life and transform how we treat disease. They want to rethink the drug discovery and development process from end-to-end by focusing on three core areas: machine learning, expansive data generation and robust therapeutic product development.


series b funding


13,824,757 Delova Biotech (China) specializes in the field of pain treatment. It uses the company’s rich R&D experience and special preparation technology platform to improve existing drugs and conduct research and development of improved new analgesics.

17,500,000 DOT Compliance (Israel) delivers the industry’s first ready to use cloud-based quality and compliance management solution for regulated industries.

21,000,000 CN Bio (United Kingdom) is a biotechnology company that specializes in organ-on-a-chip technology.

24,000,000 Qlaris Bio (Massachusetts, US) focuses on developing first-in-class therapies for serious and debilitating ophthalmic diseases.

25,000,000 Pathios Therapeutics (United Kingdom) is a biotech company focused on the development of therapies for autoimmune diseases and cancer.

29,258,745 EnteroBiotix (United Kingdom) is a developer of novel medicinal products intended to restore health and prevent bacterial infections.

47,000,000 Cerevance (Massachusetts, US) is a biotechnology company that develops novel therapeutics for neurological diseases.

132,000,000 Alterome Therapeutics (California, US) is a biopharmaceutical company developing alteration-specific targeted therapies.

158,000,000 TORL BioTherapeutics (California, US) is a clinical-stage biopharmaceutical business focused on creating innovative, antibody-based medicines


series c funding


13,828,007 SmartNuclide (China) is a biopharmaceutical company that develops biological drug products.

26,000,000 Evergreen Theragnostics (New Jersey, US) is a contract development and manufacturing platform that provides radiopharmaceutical development services.

55,000,000 Asher Bio (California, US) is a biotechnology company that specializes in the fields of therapeutics builds better immunotherapy for cancer.

132,500,000 Endeavor BioMedicines (California, US) develops new treatments targeting the underlying causes of pulmonary fibrosis.

160,500,000 Obsidian Therapeutics (Massachusetts, US) is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.


series d funding


36,000,000 Variantyx (Massachusetts, US) is a molecular diagnostics company specializing in advanced genetic testing and diagnostics.

55,226,497 IMPACT Therapeutics (China) is a therapeutics company dedicated to the development of similar drugs to treat cancer.


series f funding


65,000,000 Binx Health’s (Massachusetts, US) point-of-care diagnostic solutions empower its partners to overcome traditional barriers to care, extend their outreach, and deliver exceptional patient experiences. It has the first FDA-cleared, CLIA-waived system for detecting chlamydia and gonorrhoea in both males (urine) and females (vaginal swabs).


companies with post-ipo equity


97,501 Sirona Biochem (Canada) is a biotechnology company developing diabetes therapeutics, as well as skin depigmenting and anti-aging agents.

668,887 Prostatype Genomics AB (Sweden) is a Med-tech company, that manufactures, markets and sells the prognostic gene test Prostatype.

750,000 PharmAla Biotech (Canada) is a biotechnology company that provides manufacturing and sales of MDMA substances to the clinical research community.

903,720 GenFlow Biosciences (Massachusetts, US) is a biotech company that develops gene therapies for slow or reverse aging in dogs and humans.

1,000,000 MAIA Biotechnology (Illinois, US) is an immuno-oncology company that focuses on developing first-in-class drugs with novel mechanisms.

1,200,000 Bio-Path Holdings (Texas, US) is a biotechnology company developing therapeutic products for the liposomal delivery of nucleic acids in cancer patients.

1,250,000 RedHill Biopharma (Israel) specializes primarily in gastrointestinal and infectious diseases within the realm of specialty biopharmaceuticals.

1,543,371 Avicanna (Canada) is a biopharmaceutical company that focuses on the development of the medical cannabis space.

1,181,893 BioNxt Solutions (Canada) mission is to develop and commercialize next-generation pharmaceuticals.

2,000,000 VBI Vaccinea (Massachusetts, US) is a biopharmaceutical company developing novel technologies that seek to expand vaccine.

2,000,000 Genetic Technologies (Australia) is a molecular diagnostics company specializing in oncology.

4,000,000 Mustang Bio (New York, US) is a clinical-stage biopharmaceutical company focused on the acquisition, development, and commercialization of novel cancer immunotherapy products designed to utilize the power of the patient’s own immune system to eliminate cancer cells.

4,000,000 PainReform Ltd (Israel) is a pharmaceutical company that specializes in the reformulation of current pain medications to benefit the patient better.

4,500,000 NeuroSense Therapeutics (Israel) is a clinical-stage drug development company, advancing a ground breaking treatment for ALS.

4,600,000 Aptevo Therapeutics (Washington, US) is a biotech company primarily focused on bringing novel oncology and haematology therapeutics to market.

4,750,000 Soligenix (New Jersey, US) is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.

4,800,000 TFF Pharmaceuticals (Texas, US) is a clinical-stage biopharmaceutical company that develops drug products for the treatment of lung diseases and conditions

5,000,000 Outlook Therapeutics (New Jersey, US) is a biopharmaceutical company that develops ophthalmic formulations.

5,208,252 Diamyd Medical (Sweden) is a Swedish diabetes company active in the field of pharmaceutical development.

5,250,000 Longeveron (Florida, US) is a biotechnology company that focuses on developing cellular therapies for chronic aging-related and life-threatening diseases.

6,000,000 Biora Therapeutics (California, US) is reimagining therapeutic delivery. It’s creating innovative smart pills designed for targeted drug delivery to the GI tract and systemic, needle-free delivery of biotherapeutics.

6,100,000 Calidi Biotherapeutics (California, US) is a clinical-stage biotechnology company developing immunotherapies for cancer.

6,600,000 Rallybio (Connecticut, US) is a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases.

7,360,623 LipUm (Sweden) operates as a biotechnology company that offers anti-inflammatory drugs.

7,432,568 Syntekabio (South Korea) is a specialist AI drug discovery and development company focused on genomic big data.

8,000,000 Cyclacel Pharmaceuticals (New Jersey, US) develops oral therapies to treat cancers and other critical diseases.

9,700,000 INmune Bio (California, US) is developing therapies that harness the patient’s immune system to treat cancer.

10,000,000 (Florida, US) Matinas Biopharma is a clinical-stage biopharmaceutical company identifying and developing therapeutics for the treatment of fungal and bacterial infections.

10,000,000 Bionano Genomics (California, US) is a biotechnology company that provides genome analysis solutions to researchers and clinicians.

14,619,348 Medicenna (Canada) is a clinical stage immunotherapy company that engineers novel, powerful and proprietary interleukins they call Superkines..

15,000,000 Citius Pharmaceuticals (New Jersey, US) is a late-stage biopharmaceutical company focused on the development and commercialization of first-in-class critical care products, with a pipeline of anti-infectives in adjunct cancer care, oncology, stem cell therapy and unique prescription products.

15,800,000 OncoCyte (California, US) is a biotechnology company that focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer.

16,500,000 Vincerx Pharma (California, US) is a recently formed clinical-stage life sciences company focused on leveraging its extensive development and oncology.

17,500,000 Surrozen (California, US) is a biopharmaceutical that focuses on unlocking the body’s regenerative power to treat injury and disease.

25,000,000 Belite Bio (California, US) is a clinical stage biopharmaceutical drug development company focused on first-in-class therapeutics targeting untreatable inherited orphan diseases and age-related metabolic diseases.

32,500,000 Gritstone bio (California, US) is a biotechnology company that develops immunotherapies for cancer and infectious diseases.

34,222,769 Hansa Biopharma (Sweden) is a biopharmaceutical company that develops immunomodulatory treatments for people living with rare immunological diseases.

36,000,000 Inovio (Pennsylvania US) is a biotech company focusing on bringing to market DNA medicines for diseases associated with HPV, cancer, and infectious diseases.

40,000,000 Benitec Biopharma (California, US) is using patented gene-silencing technology to develop drugs for chronic and life-threatening human diseases.

40,000,000 Leap Therapeutics (Massachusetts, US) is a clinical-stage biopharmaceutical company for development of targeted and immuno-oncology therapeutics.

45,000,000 Protara Therapeutics (New York, US) develops transformative therapies for people with cancer and rare diseases with limited treatment options.

55,000,000 Biodesix (Colorado, US) is a data-driven diagnostic solutions company that provides lung cancer diagnostic testing and biopharma services.

59,000,000 Oculis (Iceland)is a clinical-stage biopharmaceutical development company focusing on ophthalmic drugs and novel drug delivery.

60,000,000 Century Therapeutics (Pennsylvania, US) is a biotechnology company that develops cell therapies for hematological and solid tumor malignancies.

70,000,000 Korro Bio (Massachusetts, US) provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms.

75,000,000 Sutro Biopharma (California, US) develops protein therapeutics by using OCFS protein synthesis technology.

100,000,000 Centessa Pharmaceuticals (Massachusetts, US) is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process.

112,500,000 Zura Bio (California, US) is a clinical-stage biotechnology company that develops medicines for immune system disorders.

120,000,000 Eliem Therapeutics (Washington, US) is a clinical-stage biotechnology company developing treatments for nervous system disorders.

130,000,000 Acrivon Therapeutics (Massachusetts, US) is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.

150,000,000 TScan Therapeutics (Massachusetts, US)is a biopharmaceutical company focused on the development of immunotherapy treatments for cancer.

175,000,000 Nurix Therapeutics (California, US) is a biopharmaceutical company that focuses on the development and discovery of small molecule drugs.

230,000,000 Biohaven (Connecticut, US) is a biopharmaceutical company that develops drug candidates targeting neurological diseases.

280,000,000 Cullinan Therapeutics (Massachusetts, US) is a developer of an externally sourced cancer therapeutics used to end a drug program quickly.


companies with post-ipo debt


219,503 Appili Therapeutics (Canada) is an anti-infective pharmaceutical development company.

483,351 Oxurion (Belgium) is a biotech drug development company focused on developing therapies for retinal disorders, now focusing on diabetic eye diseases.

710,776 Aegirbio (California, US) is a diagnostics company offering tests to monitor and optimize the dosing of biological drugs.

863,618 Betterlife (Canada) is a bio-pharma corporation engaged in the production and commercialization of nutraceuticals and pharmaceuticals.

1,500,000 Windtree (Pennsylvania, US) is a clinical-stage focused on developing novel surfactant therapies for respiratory diseases and other potential applications.

5,000,000 NKGen Biotech (California, US) is restoring immune function through the development of unique natural killer (NK) cell therapies for the treatment of cancer.

20,000,000 BioLineRx (Israel)is a late clinical-stage biopharmaceutical development company that focuses on oncology.

22,000,000 Dare Bioscience (California, US)is a healthcare company committed to the development and commercialization of innovative products  in women’s reproductive health.

60,000,000 Zevra Therapeutics (Florida, US) is a biopharmaceutical company focused on discovering and developing therapies for pain, ADHD, and other CNS diseases.

75,000,000 Tarsus Pharmaceuticals (California, US) is a late clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutic candidates to address large market opportunities, initially in ophthalmic conditions, where there are limited treatment alternatives.

150,000,000 Rhythm (Massachusetts, US) is a biopharmaceutical company focused on developing and commercializing peptide therapeutics.

200,000,000 Mesa Laboratories (Colorado, US) acquires, develops, manufactures and markets high-quality measurement instruments and accessories.

500,000,068 Intra-Cellular Therapies (New York, US) develops drugs for the treatment of neuropsychiatric and neurologic diseases, and other disorders of the CNS.

620,700,000 Exact Sciences (Wisconsin, US) is the developer and manufacturer of Cologuard, a non-invasive screening test for the early detection of colorectal cancer.

2,000,000,000 ICON (Ireland)is a global provider of outsourced drug development services to biopharma, medical device, biosimilar and generic organizations.


companies with debt financing


109,341 Antion Biosciences (Switzerland) is a cell and gene engineering company developing highly innovative allogeneic therapies.

109,428 Isospec Analytics SA (Switzerland) is a life science company that aims at simplifying molecular identification. They are unlocking the potential of glycomics and metabolomics in disease biomarker discovery and for the development of safer nutritional and pharmaceutical products.

220,000 iQure Pharma (Delaware, US) is a global biotech company that develops new therapeutics for neurodegenerative diseases.

35,000,000 SynOx Therapeutics (Ireland) is a biotechnology research company that focused on developing the treatment of diffuse tenosynovial giant cell tumours.


corporate round


1,479,492 Protium Science (South Korea) is a drug research and development company that provides analytical and quality assurance services.


other unknown funding rounds


690,378 Big Vision (China) is a treatment system developer, that develops and manufactures ophthalmic disease diagnosis and analysis systems.

1,083,813 Medibiofarma (Spain) provides small molecule drugs for the treatment of cancer, activation of the immune system, treatment of non-cancer diseases, and target related diseases. They also provide drugs for life threatening conditions.

1,100,166 AI Medical Technology (Sweden) developing AI powered diagnostic solutions for the diagnosis of all skin cancers.

1,888,995 Epistemic AI (Connecticut, US) we are building the next generation of tools to accelerate biomedical research with AI and NLP.

1,243,549 Monument Therapeutics (United Kingdom) develops products to treat serious diseases of the central nervous system.

2,325,500 1200 Pharma (California, US) is a medicinal chemistry technology company that accelerates pre-clinical drug discovery and clinical approval timelines.

2,500,000 Genomate Health (Massachusetts, US) is a digital health company that develops computational (AI) solutions for personalized medicine.

3,000,000 5C Network (India) is a medical diagnostics platform focusing on hyperlocal healthcare insights and advanced diagnostic tools.

3,034,380 StapleBio (Japan) is a bio-tech company that focuses on the research and development of pharmaceuticals based on staple nucleic acid technology.

4,906,587 RheumaGen (Colorado, US) is a gene-editing technology developing therapeutics to cure rheumatoid arthritis.

5,000,000 Flagship Biosciences (Colorado, US) delivers comprehensive tissue profiling using our Artificial Intelligence (AI) enabled pathology platform.

5,000,000 Owlstone Medical (United Kingdom) is a diagnostics company that developed a non-invasive breathalyzer for infectious disease detection.

5,079,995 Orange Grove Bio (Ohio, US) is a preclinical drug investment and development platform.

5,172,484 Alphyn Biologics (Ohio, US) is a life science company that develops proprietary drug therapy for treating skin diseases.

7,000,000 Thrixen (Singapore) is a biotech/Medtech company that aims to revolutionise the diagnostic technology for the detection of biomarkers at the chemistry level to unlock the next generation of diagnostic and health care monitoring tools that are simple and accessible at the point of care/need.

8,032,733 PlaqueTec (United Kingdom) is pioneering the development of biomarker-based strategies to transform the prevention, diagnosis, and treatment of Coronary Artery Disease, the leading cause of death worldwide.

10,000,000 Transcripta Bio (California, US) is a company that focuses on drug development at a size and pace never seen before, with a lower risk.

10,200,000 Sparrow Pharmaceuticals (Oregon, US) is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.

13,400,781 Acta Pharmaceuticals (Massachusetts, US) is a new Alzheimer’s drug development company.

16,074,741 4P-Pharma (France) is a clinical-stage company that develops regenerating active drugs and therapies to cure untreated serious diseases.

16,533,245 Cognivia (Belgium) develops analytical tools to optimize and speed the clinical development of novel medicines.

23,615,186 Theolytics (United Kingdom) is a clinical stage biotechnology company developing next-generation viral therapies.

24,000,000 Biofidelity (United Kingdom) developed a molecular diagnostics assay that enables the rapid detection of target DNA sequences to enable early detection of disease and better targeting of treatments.

29,858,043 Iambic Therapeutics (California, US) is disrupting the therapeutics landscape with its unique AI-driven drug-discovery platform.

31,268,683 Accession Therapeutics (United Kingdom) is developing novel immuno-oncology therapeutics combining high specificity and potency to counter tumour diversity.

48,000,000 SeLux Diagnostics (Massachusetts, US) is a developer of a next-generation phenotyping platform that provides personalized antimicrobial therapies to patients.

58,000,000 Biolinq (California, US) develops a wearable biosensor platform that is capable of measuring blood level information.

60,500,000 Nucleai (Israel) is a spatial biology company that has developed an AI-powered platform to enhance drug development and improve patient outcomes.



If you’re a biotech startup looking for talent, or you’d like to learn more about our recruitment services, submit your vacancy and a recruitment consultant that specialises in your biotech field will be in touch shortly.

Alternatively, are you seeking advice on your next move? I’m here to help. Register with us today to schedule a confidential discussion about your career prospects.